Concepedia

Carl Matthews

CM

Statistics

Publications

4

Citations

325

H-Index

4

Active since

2012

Affiliations

AstraZeneca (United Kingdom)(Current)

Carl Matthews is an author at AstraZeneca (United Kingdom) specializing in drug discovery, medicine, and extracellular matrix.

ORCID

Top concepts

Publications per year

2012–2021

4

Publications

4

Exosomal delivery of doxorubicin enables rapid cell entry and enhanced in vitro potency

Christina Schindler, Andie Collinson, Carl Matthews et al. · PLoS ONE · 2019 · 191 citations · Full text

, , +20

High affinity single-chain variable fragments are specific and versatile targeting motifs for extracellular vesicles

Andrea Longatti, Christina Schindler, Andie Collinson et al. · Nanoscale · 2018 · 93 citations · Full text

Protein engineering and preclinical development of a <scp>GM</scp>‐<scp>CSF</scp> receptor antibody for the treatment of rheumatoid arthritis

RR Minter, E. Suzanne Cohen, B Wang et al. · British Journal of Pharmacology · 2012 · 24 citations · Full text

Antisense oligonucleotide activity in tumour cells is influenced by intracellular LBPA distribution and extracellular vesicle recycling

Alexander Kapustin, Paul R. J. Davey, David Longmire et al. · Communications Biology · 2021 · 17 citations · Full text

1–4 of 4